Prof. Joaquim Carreras

School of Medicine

Tokai University, Japan

Associate Professor

E-mail: [email protected]; [email protected]; [email protected]

Qualifications

2010 Ph.D., Universitat de Barcelona, Spain

2005 Specialist, Hospital Clinic Barcelona / Spanish Ministry of Health, Spain

2000 Bachelor of Medicine, Universitat de Barcelona, Spain

Publications (Selected)

1. Suehara, Y., Sakamoto, K., Fujisawa, M., Fukumoto, K., Abe, Y., Makishima, K., ... & Sakata-Yanagimoto, M. (2025). Discrete genetic subtypes and tumor microenvironment signatures correlate with peripheral T-cell lymphoma outcomes. Leukemia, 1-12.
2. Katagiri, S., Akahane, D., Takeyama, K., Sato, N., Takayama, N., Ando, J., ... & Gotoh, A. (2025). TP53 deletion is associated with poor survival of adult ALK-positive ALCL patients receiving CHOP-based chemotherapy. Annals of Hematology, 1-6.
3. Carreras, J., Roncador, G., & Hamoudi, R. (2024). Ulcerative Colitis, LAIR1 and TOX2 Expression, and Colorectal Cancer Deep Learning Image Classification Using Convolutional Neural Networks. Cancers, 16(24), 4230.
4. Carreras, J. (2024). Celiac Disease Deep Learning Image Classification Using Convolutional Neural Networks. Journal of Imaging, 10(8), 200.
5. Mashiko, T., Carreras, J., Ogasawara, T., Masuoka, Y., Ei, S., Takahashi, S., ... & Nakagohri, T. (2024). Intrahepatic cholangiocarcinoma with arterial phase hyperenhancement and specialized tumor microenvironment associated with good prognosis after radical resection: A single-center retrospective study. Surgery, 176(2), 259-266.
6. Carreras, J., & Hamoudi, R. (2024). Anomaly Detection and Artificial Intelligence Identified the Pathogenic Role of Apoptosis and RELB Proto-Oncogene, NF-kB Subunit in Diffuse Large B-Cell Lymphoma. BioMedInformatics, 4(2), 1480-1505.
7. Carreras, J., Hamoudi, R., & Nakamura, N. (2024). Artificial intelligence and classification of mature lymphoid neoplasms. Exploration of Targeted Anti-tumor Therapy, 5(2), 332.
8. Carreras, J., & Nakamura, N. (2024). Artificial Intelligence, Lymphoid Neoplasms, and Prediction of MYC, BCL2, and BCL6 Gene Expression Using a Pan-Cancer Panel in Diffuse Large B-Cell Lymphoma. Hemato, 5(2), 119-143.
9. Carreras, J., Ikoma, H., Kikuti, Y. Y., Miyaoka, M., Hiraiwa, S., Tomita, S., ... & Nakamura, N. (2024). Mutational, immune microenvironment, and clinicopathological profiles of diffuse large B-cell lymphoma and follicular lymphoma with BCL6 rearrangement. Virchows Archiv, 484(4), 657-676.
10. Carreras, J., Ikoma, H., Kikuti, Y. Y., Miyaoka, M., Hiraiwa, S., Tomita, S., ... & Nakamura, N. (2024). Mutational, immune microenvironment, and clinicopathological profiles of diffuse large B-cell lymphoma and follicular lymphoma with BCL6 rearrangement. Virchows Archiv, 484(4), 657-676.
11. Kameda, K., Yanagiya, R., Miyatake, Y., Carreras, J., Higuchi, H., Murayama, H., ... & Kotani, A. (2023). The hepatic niche leads to aggressive natural killer cell leukemia proliferation through the transferrin–transferrin receptor 1 axis. Blood, The Journal of the American Society of Hematology, 142(4), 352-364.
12. Carreras, J. (2023). The pathobiology of follicular lymphoma. Journal of clinical and experimental hematopathology, 63(3), 152-163.
13. Carreras, J. (2023). The pathobiology of follicular lymphoma. Journal of clinical and experimental hematopathology, 63(3), 152-163.
14. Carreras, J., Roncador, G., & Hamoudi, R. (2022). Artificial intelligence predicted overall survival and classified mature B-cell neoplasms based on immuno-oncology and immune checkpoint panels. Cancers, 14(21), 5318.
15. Carreras, J. (2022, August). Artificial intelligence analysis of celiac disease using an autoimmune discovery transcriptomic panel highlighted pathogenic genes including BTLA. In Healthcare (Vol. 10, No. 8, p. 1550). MDPI.
16. Shiraiwa, S., Kikuti, Y. Y., Carreras, J., Kondo, Y., Ohmachi, K., Ogawa, Y., ... & Ando, K. (2022). 9p24. 1 Genetic Alteration and PD-L1 Expression Are Characteristic of De Novo and Methotrexate-associated Epstein-Barr Virus–positive Hodgkin Lymphoma, But Not Methotrexate-associated Hodgkin-like Lesions. The American Journal of Surgical Pathology, 46(8), 1017-1024.
17. Carreras, J., Kikuti, Y. Y., Miyaoka, M., Hiraiwa, S., Tomita, S., Ikoma, H., ... & Nakamura, N. (2022). The use of the random number generator and artificial intelligence analysis for dimensionality reduction of follicular lymphoma transcriptomic data. BioMedInformatics, 2(2), 268-280.
18. Ikoma, H., Miyaoka, M., Hiraiwa, S., Yukie Kikuti, Y., Shiraiwa, S., Hara, R., ... & Nakamura, N. (2022). Clinicopathological analysis of follicular lymphoma with BCL2, BCL6, and MYC rearrangements. Pathology International, 72(6), 321-331.
19. Kudo, K., Miki, Y., Carreras, J., Nakayama, S., Nakamoto, Y., Ito, M., ... & Kotani, A. (2022). Secreted phospholipase A2 modifies extracellular vesicles and accelerates B cell lymphoma. Cell Metabolism, 34(4), 615-633.
20. Carreras, J., Nakamura, N., & Hamoudi, R. (2022, January). Artificial intelligence analysis of gene expression predicted the overall survival of mantle cell lymphoma and a large pan-cancer series. In Healthcare (Vol. 10, No. 1, p. 155). MDPI.

Profile Details

WoS ResearcherID: AAS-4272-2021

https://orcid.org/0000-0002-6129-8299

http://carreras.med.u-tokai.ac.jp/

https://www.researchgate.net/profile/Joaquim_Carreras

http://www.linkedin.com/in/joaquim-carreras-tokai

https://scholar.google.com/citations?user=I26vIxUAAAAJ&hl=ja&oi=sra

https://www.cantab.net/users/joaquim.carreras/